Performa Ltd (US)’s Pediatrix Medical MD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$9.99K Hold
467
﹤0.01% 30
2025
Q4
$9.99K Hold
467
﹤0.01% 27
2025
Q3
$7.82K Hold
467
﹤0.01% 30
2025
Q2
$6.7K Hold
467
﹤0.01% 31
2025
Q1
$6.77K Hold
467
﹤0.01% 35
2024
Q4
$6.13K Hold
467
﹤0.01% 36
2024
Q3
$5.41K Sell
467
-6,233
-93% -$58.8K ﹤0.01% 36
2024
Q2
$50.6K Buy
6,700
+2,900
+76% +$24K 0.02% 23
2024
Q1
$38.1K Buy
3,800
+800
+27% +$7.44K 0.02% 24
2023
Q4
$27.9K Buy
3,000
+1,700
+131% +$17.6K 0.01% 25
2023
Q3
$16.5K Buy
1,300
+50
+4% +$686 0.01% 29
2023
Q2
$17.8K Buy
1,250
+150
+14% +$2.11K 0.01% 31
2023
Q1
$16.4K Hold
1,100
0.01% 32
2022
Q4
$16.3K Buy
1,100
+400
+57% +$6.53K 0.01% 35
2022
Q3
$12K Buy
700
+500
+250% +$10.1K 0.01% 35
2022
Q2
$4K Buy
200
+100
+100% +$2.04K ﹤0.01% 44
2022
Q1
$2K Hold
100
﹤0.01% 48
2021
Q4
$3K Hold
100
﹤0.01% 44
2021
Q3
$3K Hold
100
﹤0.01% 42
2021
Q2
$3K Hold
100
﹤0.01% 29
2021
Q1
$3K Sell
100
-50
-33% -$1.28K ﹤0.01% 26
2020
Q4
$4K Buy
+150
New +$2.82K ﹤0.01% 19

Other funds holding MD

Performa Ltd (US)'s MD Position: Q1 2026 in Review

Performa Ltd (US) held its Pediatrix Medical (MD) position steady in Q1 2026 at 467 shares worth $9.99K. The position accounts for ﹤0.01% of the portfolio, ranked #30.

Performa Ltd (US) first reported a position in MD in Q4 2020 and has held it in 22 quarters since. The position peaked at $50.6K in Q2 2024. 296 funds tracked by Wall St. Rank hold MD as of Q1 2026.

  • Performa Ltd (US) held 467 shares of Pediatrix Medical worth $9.99K as of Q1 2026.
  • Performa Ltd (US) left its Pediatrix Medical share count unchanged in Q1 2026.
  • Pediatrix Medical made up ﹤0.01% of Performa Ltd (US)'s portfolio in Q1 2026, its #30 holding.
  • Performa Ltd (US) first reported a position in Pediatrix Medical in Q4 2020 and has held it in 22 quarters since.
  • Performa Ltd (US)'s Pediatrix Medical position peaked at $50.6K in Q2 2024.
  • 296 funds tracked by Wall St. Rank held Pediatrix Medical as of Q1 2026.

Based on Performa Ltd (US)'s 13F filing for Q1 2026, filed 6 May 2026.